PHILLIPS, GAIL LEWIS,SAMPATH, DEEPAK,WERTZ, INGRID
申请号:
CA2990465
公开号:
CA2990465A1
申请日:
2016.07.06
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer.